BIOMAT Database Logo BIOMAT Database Logo

Macrolide Resistant Mycoplasma pneumoniae in Community Acquired Pneumonia. 2020

Serena M Varghese, and Vishakha V Kerkar
Department of Pediatrics, Rajagiri Hospital, Aluva, Kochi, 683112, India. serena.mohan@rajagirihospital.com.

UI MeSH Term Description Entries
D009177 Mycoplasma pneumoniae Short filamentous organism of the genus Mycoplasma, which binds firmly to the cells of the respiratory epithelium. It is one of the etiologic agents of non-viral primary atypical pneumonia in man. Eaton Agent
D011019 Pneumonia, Mycoplasma Interstitial pneumonia caused by extensive infection of the lungs (LUNG) and BRONCHI, particularly the lower lobes of the lungs, by MYCOPLASMA PNEUMONIAE in humans. In SHEEP, it is caused by MYCOPLASMA OVIPNEUMONIAE. In CATTLE, it may be caused by MYCOPLASMA DISPAR. Mycoplasma Pneumonia,Pneumonia, Primary Atypical,Mycoplasma dispar Infection,Mycoplasma ovipneumoniae Infection,Mycoplasma pneumoniae Infection,Atypical Pneumonia, Primary,Atypical Pneumonias, Primary,Mycoplasma Pneumonias,Mycoplasma dispar Infections,Mycoplasma ovipneumoniae Infections,Mycoplasma pneumoniae Infections,Pneumonias, Mycoplasma,Pneumonias, Primary Atypical,Primary Atypical Pneumonia,Primary Atypical Pneumonias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D017714 Community-Acquired Infections Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility. Community Acquired Infection,Community-Acquired Infection,Infections, Community-Acquired,Acquired Infection, Community,Acquired Infections, Community,Community Acquired Infections,Infection, Community Acquired,Infection, Community-Acquired,Infections, Community Acquired
D018942 Macrolides A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties. Macrolide
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Serena M Varghese, and Vishakha V Kerkar
Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
October 2010, International journal of antimicrobial agents,
Serena M Varghese, and Vishakha V Kerkar
Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
July 2020, Emerging infectious diseases,
Serena M Varghese, and Vishakha V Kerkar
Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
May 2012, BMC infectious diseases,
Serena M Varghese, and Vishakha V Kerkar
Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
November 2009, Respirology (Carlton, Vic.),
Serena M Varghese, and Vishakha V Kerkar
Community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in adults.
January 2014, Internal medicine (Tokyo, Japan),
Serena M Varghese, and Vishakha V Kerkar
Macrolide-resistant Mycoplasma pneumoniae in adults with community acquired pneumonia: challenges and risks.
February 2020, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit,
Serena M Varghese, and Vishakha V Kerkar
Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland.
January 2014, Swiss medical weekly,
Serena M Varghese, and Vishakha V Kerkar
Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.
April 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Serena M Varghese, and Vishakha V Kerkar
First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy.
January 2019, BioMed research international,
Serena M Varghese, and Vishakha V Kerkar
Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age.
February 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Copied contents to your clipboard!